Skip to main content
SpringerLink
Log in

No investment return biggest barrier to low-cost drugs

  • Comment
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Respectively of the Uniformed Services University of the Health Sciences in Bethesda (MD, USA) and the Yale School of Medicine and Yale Center for Outcomes Research (New Haven, CT, USA).

Reference

  • Kellermann AL, et al. Obstacles to Developing Cost-Lowering Health Technology: The Inventor's Dilemma. Journal of the American Medical Association : 17 Aug 2015. Available from: URL: http://dx.doi.org/10.1001/jama.2015.10114

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

No investment return biggest barrier to low-cost drugs. PharmacoEcon Outcomes News 735, 4 (2015). https://doi.org/10.1007/s40274-015-2378-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2378-1

Search

Navigation